Is a complete CLLS research report available?

No complete published report is available for Cellectis S.A. (CLLS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cellectis S.A. (CLLS)

NASDAQ: CLLS · USD

$2.84

+0.07 (+2.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CLLS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	214.3M
Revenue (ttm)	75.1M
Net income (ttm)	-67.2M
EPS (ttm)	-$0.67
Shares out	72.6M
Volume	23,673
Beta	2.77
Price target	$7.60	+167.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 75.1M
Net income (ttm): -67.2M
EPS (ttm): -$0.67
Market cap: 214.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CLLS indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001627281
Company name	Cellectis S.A.
Country	France
Country code	US
Cusip	15117K103
Employees	229
Employees Change	7%
Employees Change Percent	3.15
Enterprise value	$112.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2007-02-07
Isin	US15117K1034
Last refreshed	2026-07-25
Market cap	$214.3M
Market cap category	Micro-Cap
Price	$2.84
Price currency	USD
Rev Per Employee	328,000x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2836
Symbol	CLLS
Website	https://www.cellectis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.38%
EV Sales Forward	1.5x
EV/Sales	1.5x
FCF yield	-18.61%
P/B ratio	3.58x
P/S ratio	2.85x
PS Forward	2.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-58.66%
EBITDA Margin	-32.48%
Gross margin	100%
Gross Profit	$75.1M
Gross Profit Growth	37.2%
Gross Profit Growth Q	-37.25%
Gross Profit Growth3 Y	46.08%
Gross Profit Growth5 Y	32.07%
Net Income	$-67.2M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-90.01%
Profit Margin	-89.51%
Profit Per Employee	$-293,581
ROA	-8.43
Roa5y	-13.8
ROCE	-28.48
ROE	-76.34
Roe5y	-60.06
ROIC	-15.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-19.62%
Cagr1y	21.91%
Cagr3y	-0.23%
Cagr5y	-27.06%
EPS Growth Years	0
Revenue Growth	37.2x
Revenue Growth Q	-37.25x
Revenue Growth Years	2x
Revenue Growth3 Y	43.38x
Revenue Growth5 Y	5.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.23
Assets	$289.2M
Cash	$185.4M
Current Assets	$204.6M
Current Liabilities	$134.5M
Debt	$82.3M
Debt Equity	$1.37
Equity	$59.9M
Interest Coverage	-5.42
Liabilities	$229.3M
Long Term Assets	$84.6M
Long Term Liabilities	$94.8M
Net Cash	$103.1M
Net Cash By Market Cap	$48.11
Net Cash Growth	187.41%
Net Debt Equity	$-1.72
Tangible Book Value	$59.7M
Tangible Book Value Per Share	$0.82
WACC	16.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.52
Net Working Capital	$-106.5M
Quick ratio	1.49
Working Capital	$70.1M
Working Capital Turnover	$0.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.78%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-88.73%
1Y total return	21.89%
200-day SMA	3.79
3Y total return	-0.7%
50-day SMA	3.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.35%
All Time High	50
All Time High Change	-94.32%
All Time High Date	2015-05-28
All Time Low	0.96
All Time Low Change	194.97%
All Time Low Date	2023-10-26
ATR	0.17
Beta	2.77
Ch YTD	-41.32
High	2.98
High52	5.48
High52 Date	2025-10-16
High52ch	-48.18%
Low	2.81
Low52	2
Low52 Date	2025-07-24
Low52ch	42%
Ma50ch	-10.13%
Premarket Change Percent	3.61
Premarket Price	$2.87
Premarket Volume	2,060
Price vs 200-day SMA	-25.01%
RSI	45.48
RSI Monthly	47.47
RSI Weekly	41.39
Sharpe ratio	0.6x
Sortino ratio	1.03
Total Return	-2.78%
Tr YTD	-41.32
Tr1m	-2.07%
Tr1w	7.99%
Tr3m	-27.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$9
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.26
Earnings Revenue Estimate	9,375,420x
Earnings Revenue Estimate Growth	-48.47x
Operating Income	$-44.1M
Operating margin	-58.66
Price target	$7.6
Price Target Change	$168
Price Target Change Top	$217

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,690,802%
Float Percent	64.31%
Net Borrowing	-17,093,000
Shares Insiders	2.19%
Shares Institutions	16.63%
Shares Out	72,601,869
Shares Qo Q	0.2%
Shares Yo Y	2.78%
Short Ratio	6.57
Short Shares	0.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-46.7M
Average Volume	16,901.7x
Bv Per Share	0.83
CAPEX	$-2.2M
Ch10y	-88.73
Ch1m	-2.07
Ch1w	7.99
Ch1y	21.89
Ch3m	-27.37
Ch3y	-0.7
Ch5y	-79.35
Ch6m	-35.75
Change	2.53%
Change From Open	-2.74
Close	2.77
Days Gap	5.42
Depreciation Amortization	11,315,000
Dollar Volume	67,231.3
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-44.1M
EBITDA	$-24.4M
EPS	$-0.67
F Score	2
FCF	$-39.9M
FCF EV Yield	-35.46x
FCF Per Share	$-0.55
Financing CF	-17,571,000
Fiscal Year End	December
Founded	1,999
Income Tax	$-377,000
Investing CF	-39,872,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-20
Ma150	3.67
Ma150ch	-22.53%
Ma20	2.92
Ma20ch	-2.67%
Net CF	-92,795,000
Next Earnings Date	2026-08-07
Open	2.92
Optionable	Yes
Position In Range	17.65
Post Close	2.84
Postmarket Change Percent	0.7
Postmarket Price	$2.86
Ppne	57,927,000
Pre Close	2.77
Price Date	2026-07-24
Ptbv Ratio	3.59
Relative Volume	1.4x
Revenue	75,112,000x
SBC By Revenue	9.05x
Share Based Comp	6,797,000
Tax By Revenue	-0.5x
Tr6m	-35.75%
Volume	23,673
Z Score	-1.07

Cellectis S.A. (CLLS)

Coverage state: Market snapshot only — no published research

Generate the first CLLS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CLLS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLLS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CLLS

Frequently asked questions